Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Histology01:27

Liver Histology

The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is covered...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Subtypes of Cholangiocarcinoma and their Translational Implications.

Gastroenterology·2026
Same author

Multi-ancestry genome-wide association meta-analysis of hepatocellular carcinoma identifies eight risk loci including MAP3K9, DHRS1, MTTP, and 8q24.21.

HGG advances·2026
Same author

SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis.

NPJ precision oncology·2026
Same author

Lower Allele Frequency of <i>TERT</i>-rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma Risk.

JCO global oncology·2026
Same author

Real-World Analysis of Multidisciplinary Roles in the Management of Hepatocellular Carcinoma: The Mayo Clinic Experience.

Journal of hepatocellular carcinoma·2026

Related Experiment Video

Updated: May 7, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Liver masses: a clinical, radiologic, and pathologic perspective.

Sudhakar K Venkatesh1, Vishal Chandan2, Lewis R Roberts3

  • 1Division of Abdominal Imaging, College of Medicine, Mayo Clinic, Rochester, Minnesota.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|September 24, 2013
PubMed
Summary

Accurately diagnosing liver masses is crucial for appropriate patient care. Multidisciplinary collaboration and advanced imaging improve the characterization and management of both benign and malignant liver lesions.

Keywords:
CholangiocarcinomaFocal Nodular HyperplasiaHepatic AdenomaHepatic HemangiomaHepatocellular CarcinomaLiver Imaging

More Related Videos

DUCT: Double Resin Casting followed by Micro-Computed Tomography for 3D Liver Analysis
12:39

DUCT: Double Resin Casting followed by Micro-Computed Tomography for 3D Liver Analysis

Published on: September 28, 2021

Related Experiment Videos

Last Updated: May 7, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

DUCT: Double Resin Casting followed by Micro-Computed Tomography for 3D Liver Analysis
12:39

DUCT: Double Resin Casting followed by Micro-Computed Tomography for 3D Liver Analysis

Published on: September 28, 2021

Area of Science:

  • Hepatology
  • Radiology
  • Pathology

Background:

  • Liver masses are common clinical findings, often detected via advanced imaging techniques.
  • Accurate diagnosis of liver lesions is critical to differentiate benign from malignant conditions, preventing misdiagnosis and ensuring timely treatment.
  • Noninvasive methods, including clinical evaluation and imaging, can characterize most liver masses.

Purpose of the Study:

  • To emphasize the importance of accurate liver mass characterization.
  • To highlight the role of multiphasic contrast imaging and understanding liver perfusion.
  • To outline the diagnostic and management pathways for liver masses.

Main Methods:

  • Clinical history and physical examination interpretation.
  • Judicious use of laboratory and imaging studies, particularly cross-sectional imaging with multiphasic contrast enhancement.
  • Liver biopsy with histologic and immunohistochemical analysis when noninvasive characterization is indeterminate.

Main Results:

  • The majority of liver masses can be characterized noninvasively through expert interpretation of imaging and clinical data.
  • Understanding liver's unique vascular perfusion patterns is key for accurate imaging-based diagnosis.
  • Liver biopsy remains essential for definitive diagnosis in indeterminate cases.

Conclusions:

  • Accurate diagnosis of liver masses guides appropriate management, ranging from observation for benign lesions to oncologic therapy for malignancies.
  • Management decisions for malignant liver masses consider tumor staging, liver function, and surgical feasibility.
  • Effective liver mass management necessitates a multidisciplinary approach involving gastroenterologists, radiologists, pathologists, surgeons, and oncologists.